Product Code: ETC100319 | Publication Date: Jun 2021 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The United Arab Emirates (UAE) Human Insulin market is driven by the increasing prevalence of diabetes and the growing healthcare infrastructure in the country. Human insulin is a critical medication used to manage diabetes, and its demand is rising due to the increasing diabetic population and the government`s initiatives to improve healthcare facilities. The UAE focus on diabetes management and patient care contributes to the demand for human insulin, making it an essential component in diabetes treatment.
The primary driver of the UAE Human Insulin market is the high prevalence of diabetes in the country. The UAE has one of the highest rates of diabetes in the world, with a significant portion of the population affected by the disease. This has led to a growing demand for diabetes management and treatment, including the use of human insulin to control blood glucose levels. Additionally, the UAE efforts to improve healthcare infrastructure and provide accessible and affordable healthcare services further drive the demand for human insulin.
The UAE Human Insulin market faces challenges related to diabetes management and patient adherence. Ensuring proper access to insulin and continuous patient education on diabetes management are crucial challenges. Additionally, the rising cost of healthcare and the affordability of insulin can be a barrier for some patients. Proper regulation and pricing policies are necessary to make human insulin accessible to all diabetic patients in the UAE.
The Covid-19 pandemic had significant impacts on the UAE Human Insulin market. Diabetic patients are considered at higher risk for severe Covid-19 outcomes, leading to increased attention to diabetes management during the pandemic. The demand for human insulin remained steady, and healthcare facilities focused on ensuring continuous access to medication for diabetic patients. The pandemic highlighted the importance of managing chronic conditions like diabetes, further emphasizing the need for human insulin.
Some key players in the UAE insulin market include Novo Nordisk, Sanofi, and Eli Lilly and Company. These companies play a significant role in providing human insulin products to meet the specific healthcare needs of the UAE diabetic population.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Arab Emirates (UAE) Human Insulin Market Overview |
3.1 United Arab Emirates (UAE) Country Macro Economic Indicators |
3.2 United Arab Emirates (UAE) Human Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 United Arab Emirates (UAE) Human Insulin Market - Industry Life Cycle |
3.4 United Arab Emirates (UAE) Human Insulin Market - Porter's Five Forces |
3.5 United Arab Emirates (UAE) Human Insulin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Arab Emirates (UAE) Human Insulin Market Revenues & Volume Share, By Diabetes Type, 2021 & 2031F |
3.7 United Arab Emirates (UAE) Human Insulin Market Revenues & Volume Share, By Delivery Devices, 2021 & 2031F |
3.8 United Arab Emirates (UAE) Human Insulin Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 United Arab Emirates (UAE) Human Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 United Arab Emirates (UAE) Human Insulin Market Trends |
6 United Arab Emirates (UAE) Human Insulin Market, By Types |
6.1 United Arab Emirates (UAE) Human Insulin Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Arab Emirates (UAE) Human Insulin Market Revenues & Volume, By Type, 2018 - 2031F |
6.1.3 United Arab Emirates (UAE) Human Insulin Market Revenues & Volume, By Analogue Insulin, 2018 - 2031F |
6.1.4 United Arab Emirates (UAE) Human Insulin Market Revenues & Volume, By Traditional Human Insulin, 2018 - 2031F |
6.2 United Arab Emirates (UAE) Human Insulin Market, By Diabetes Type |
6.2.1 Overview and Analysis |
6.2.2 United Arab Emirates (UAE) Human Insulin Market Revenues & Volume, By Type 1 Diabetes, 2018 - 2031F |
6.2.3 United Arab Emirates (UAE) Human Insulin Market Revenues & Volume, By Type 2 Diabetes, 2018 - 2031F |
6.2.4 United Arab Emirates (UAE) Human Insulin Market Revenues & Volume, By Gestational Diabetes, 2018 - 2031F |
6.2.5 United Arab Emirates (UAE) Human Insulin Market Revenues & Volume, By Prediabetes, 2018 - 2031F |
6.3 United Arab Emirates (UAE) Human Insulin Market, By Delivery Devices |
6.3.1 Overview and Analysis |
6.3.2 United Arab Emirates (UAE) Human Insulin Market Revenues & Volume, By Syringes, 2018 - 2031F |
6.3.3 United Arab Emirates (UAE) Human Insulin Market Revenues & Volume, By Pens, 2018 - 2031F |
6.3.4 United Arab Emirates (UAE) Human Insulin Market Revenues & Volume, By Pumps, 2018 - 2031F |
6.3.5 United Arab Emirates (UAE) Human Insulin Market Revenues & Volume, By Others, 2018 - 2031F |
6.4 United Arab Emirates (UAE) Human Insulin Market, By End-users |
6.4.1 Overview and Analysis |
6.4.2 United Arab Emirates (UAE) Human Insulin Market Revenues & Volume, By Home Healthcare, 2018 - 2031F |
6.4.3 United Arab Emirates (UAE) Human Insulin Market Revenues & Volume, By Hospitals, 2018 - 2031F |
6.4.4 United Arab Emirates (UAE) Human Insulin Market Revenues & Volume, By Over The Counter (OTC), 2018 - 2031F |
6.4.5 United Arab Emirates (UAE) Human Insulin Market Revenues & Volume, By Clinics, 2018 - 2031F |
6.4.6 United Arab Emirates (UAE) Human Insulin Market Revenues & Volume, By Others, 2018 - 2031F |
7 United Arab Emirates (UAE) Human Insulin Market Import-Export Trade Statistics |
7.1 United Arab Emirates (UAE) Human Insulin Market Export to Major Countries |
7.2 United Arab Emirates (UAE) Human Insulin Market Imports from Major Countries |
8 United Arab Emirates (UAE) Human Insulin Market Key Performance Indicators |
9 United Arab Emirates (UAE) Human Insulin Market - Opportunity Assessment |
9.1 United Arab Emirates (UAE) Human Insulin Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Arab Emirates (UAE) Human Insulin Market Opportunity Assessment, By Diabetes Type, 2021 & 2031F |
9.3 United Arab Emirates (UAE) Human Insulin Market Opportunity Assessment, By Delivery Devices, 2021 & 2031F |
9.4 United Arab Emirates (UAE) Human Insulin Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 United Arab Emirates (UAE) Human Insulin Market - Competitive Landscape |
10.1 United Arab Emirates (UAE) Human Insulin Market Revenue Share, By Companies, 2024 |
10.2 United Arab Emirates (UAE) Human Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |